UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2598 - 2607
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Mycosis Fungoides - classification | Lymph Nodes - pathology | Skin Neoplasms - drug therapy | Randomized Controlled Trials as Topic - methods | Humans | Mycosis Fungoides - blood | Neoplasm Staging - standards | Sezary Syndrome - blood | Skin Neoplasms - blood | Randomized Controlled Trials as Topic - standards | Neoplasm Staging - methods | Mycosis Fungoides - pathology | Sezary Syndrome - drug therapy | Clinical Trials as Topic - standards | Sezary Syndrome - pathology | Skin - pathology | Severity of Illness Index | Sezary Syndrome - classification | Skin Neoplasms - pathology | Treatment Outcome | Sezary Syndrome - psychology | Tumor Burden | Viscera - pathology | Mycosis Fungoides - drug therapy | Outcome Assessment (Health Care) - standards | Skin Neoplasms - classification | Skin Neoplasms - psychology | Quality of Life | Mycosis Fungoides - psychology | Clinical Trials as Topic - methods | Research Design | Sezary syndrome | Classification | Standardization | Clinical trials | Mycosis fungoides | Data processing | Skin diseases | Non-Hodgkin's lymphoma | Blood | Lymph nodes | T-cell lymphoma | Cancer | Index Medicus | Special | Hema14 | Hema11 | Hema10
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1192 - 1204
Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Agents, Immunological - administration & dosage | United States | Humans | Middle Aged | Histone Deacetylase Inhibitors - administration & dosage | Drug Resistance, Neoplasm | Male | Lymphoma, T-Cell, Cutaneous - drug therapy | Sezary Syndrome - mortality | Mycosis Fungoides - pathology | Antibodies, Monoclonal, Humanized - administration & dosage | Time Factors | Sezary Syndrome - drug therapy | Female | Mycosis Fungoides - mortality | Sezary Syndrome - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Lymphoma, T-Cell, Cutaneous - mortality | Europe | Japan | Neoplasm Recurrence, Local | Vorinostat - adverse effects | Mycosis Fungoides - drug therapy | Lymphoma, T-Cell, Cutaneous - pathology | Antineoplastic Agents, Immunological - adverse effects | Progression-Free Survival | Aged | Australia | Neoplasm Staging | Vorinostat - administration & dosage | Histone Deacetylase Inhibitors - adverse effects | Lymphomas | T cells | Analysis | Vorinostat | Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 09/2007, Volume 31, Issue 9, pp. 1430 - 1438
Mycosis fungoides | Folliculotropic mycosis fungoides | Pilotropic mycosis fungoides | Follicular mycosis fungoides | Cutaneous T-cell lymphoma | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques | Immunohistochemistry | Skin Neoplasms - pathology | Mycosis Fungoides - immunology | Langerhans Cells - pathology | Skin Neoplasms - immunology | Humans | Hyperplasia | Middle Aged | Skin Neoplasms - chemistry | Male | Antigens, CD1 - analysis | CD8 Antigens - analysis | Hair Follicle - pathology | Plasma Cells - pathology | Mycosis Fungoides - pathology | CD4 Antigens - analysis | Skin Neoplasms - diagnosis | Mucins - analysis | Adult | Female | Aged | Eosinophils - pathology | Mycosis Fungoides - chemistry | Mycosis Fungoides - diagnosis | Index Medicus
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 49, Issue 13, pp. 2859 - 2868
Hematology, Oncology and Palliative Medicine | Mycosis fungoides | Cutaneous lymphoma | Sezary syndrome | Prognostic index | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Tumors | Multivariate Analysis | Humans | Middle Aged | Male | Mycosis Fungoides - blood | Sezary Syndrome - blood | Skin Neoplasms - blood | Sezary Syndrome - mortality | Mycosis Fungoides - pathology | Sezary Syndrome - diagnosis | Time Factors | Mycosis Fungoides - therapy | Skin Neoplasms - mortality | Skin Neoplasms - diagnosis | Female | Mycosis Fungoides - mortality | Sezary Syndrome - pathology | Mycosis Fungoides - diagnosis | Skin Neoplasms - pathology | Skin Neoplasms - therapy | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Biomarkers, Tumor - blood | Disease-Free Survival | L-Lactate Dehydrogenase - blood | Sezary Syndrome - therapy | Neoplasm Staging | Mycoses | Index Medicus | Age
Journal Article
JAAD Case Reports, ISSN 2352-5126, 03/2019, Volume 5, Issue 3, pp. 231 - 233
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 32, pp. 3766 - 3773
Life Sciences & Biomedicine | Oncology | Science & Technology | L-Lactate Dehydrogenase - metabolism | Predictive Value of Tests | Prognosis | Age Factors | Humans | Middle Aged | Male | Sezary Syndrome - mortality | Mycosis Fungoides - pathology | Mycosis Fungoides - metabolism | Skin Neoplasms - mortality | Adult | Female | Mycosis Fungoides - mortality | Sezary Syndrome - pathology | Skin Neoplasms - pathology | Risk Factors | Kaplan-Meier Estimate | Survival Rate | Models, Statistical | Skin - enzymology | Cell Transformation, Neoplastic - metabolism | Skin Neoplasms - metabolism | Sezary Syndrome - metabolism | L-Lactate Dehydrogenase - blood | Aged | Cell Transformation, Neoplastic - pathology | Neoplasm Staging | Index Medicus | Malalties de la pell | Case studies | Mycosis | Micosi | Estudi de casos | Oncologia | Skin diseases | Lymphomas | Limfomes | Bone2 | Nmel | ORIGINAL REPORTS | Hema11 | Hema10
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2017, Volume 77, pp. 57 - 74
Hematology, Oncology and Palliative Medicine | Chemotherapy | Total skin electron beam therapy | Immunotherapy | Skin-directed therapy | Mycosis fungoides | Retinoids | Sézary syndrome | Radiotherapy | Cutaneous T-cell lymphomas | Phototherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Skin Neoplasms - pathology | Immunotherapy - methods | Skin Neoplasms - therapy | Humans | Interferon-alpha - therapeutic use | Electrons - therapeutic use | Dermatologic Agents - therapeutic use | Consensus | Biological Factors - therapeutic use | Mycosis Fungoides - pathology | Phototherapy - methods | Retinoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mycosis Fungoides - therapy | Sezary Syndrome - therapy | Watchful Waiting | Combined Modality Therapy - methods | Histone Deacetylase Inhibitors - therapeutic use | Hematopoietic Stem Cell Transplantation - methods | Neoplasm Staging | Sezary Syndrome - pathology | Practice Guidelines as Topic | Mycoses | Care and treatment | Research | Oncology, Experimental | Cancer | Medical research | Cell survival | Life expectancy | Mycosis | Medical treatment | Clinical trials | Stem cell transplantation | T cell receptors | Transplantation | Patients | Epidemiology | Lymphoma | Neoplasms | Life span | Skin | Index Medicus
Journal Article
8.
Full Text
Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management
American journal of hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 1085 - 1102
Life Sciences & Biomedicine | Hematology | Science & Technology | Sezary Syndrome - immunology | Mycosis Fungoides - immunology | Prognosis | Risk Assessment | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Lymphoma, T-Cell, Cutaneous - diagnosis | Lymphoma, T-Cell, Cutaneous - immunology | Humans | Histone Deacetylase Inhibitors - administration & dosage | Lymphoma, T-Cell, Cutaneous - therapy | Stem Cell Transplantation | Sezary Syndrome - diagnosis | Mycosis Fungoides - therapy | Sezary Syndrome - therapy | Skin Neoplasms - diagnosis | Survival Analysis | Histone Deacetylase Inhibitors - therapeutic use | Neoplasm Staging | Histone Deacetylase Inhibitors - adverse effects | Mycosis Fungoides - diagnosis | Chemotherapy | Dermatology | Stem cells | Formulae, receipts, prescriptions | Mycoses | Dermatologic agents | Transplantation | Non-Hodgkin's lymphomas | Diagnosis | T cells | Cancer | Histone deacetylase | Mycosis | Immunoproliferative diseases | Mycosis fungoides | Stem cell transplantation | Lymphocytes T | Patients | Metastases | Lymphocytes | Skin diseases | T-cell lymphoma | Index Medicus
Journal Article